Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2APNA | ISIN: US09075A1088 | Ticker-Symbol:
NASDAQ
06.06.25 | 22:00
6,690 US-Dollar
+2,76 % +0,180
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOVENTUS INC Chart 1 Jahr
5-Tage-Chart
BIOVENTUS INC 5-Tage-Chart

Aktuelle News zur BIOVENTUS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBioventus Inc. - 8-K, Current Report1
BIOVENTUS Aktie jetzt für 0€ handeln
06.05.Bioventus reiterates 2025 guidance with focus on growth and profitability1
06.05.Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance1
06.05.Bioventus Inc. Q1 Loss Narrows-
06.05.Bioventus Non-GAAP EPS of $0.08 beats by $0.06, revenue of $123.88M beats by $1.17M1
06.05.Bioventus Inc. - 10-Q, Quarterly Report1
06.05.Bioventus Inc. - 8-K, Current Report1
06.05.Bioventus, Inc.: Bioventus Reports First Quarter Financial Results89Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0%First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year periodNon-GAAP earnings*...
► Artikel lesen
05.05.Examining the Future: Bioventus' Earnings Outlook1
11.03.Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million1
11.03.Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday34
11.03.Bioventus Q4 Results Beat Market; Sees FY25 Earnings, Sales Above Street; Stock Climbs In Pre-market1
11.03.Bioventus Inc. - S-8, Securities to be offered to employees in employee benefit plans1
11.03.Bioventus Inc. - 10-K, Annual Report1
11.03.Bioventus Inc. - 8-K, Current Report1
11.03.Bioventus Non-GAAP EPS of $0.15 beats by $0.07, revenue of $153.64M beats by $8.48M1
11.03.Bioventus, Inc.: Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results147Accelerated fourth quarter sales growth to 13.5%Fourth quarter gross margin expanded 310 bps and adjusted gross margin* expanded 230 bpsFourth quarter cash from operations of $19.3 million increased...
► Artikel lesen
28.02.Bioventus, Inc.: Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 20252
03.01.Bioventus Inc. - 8-K, Current Report-
02.01.Bioventus divests Advanced Rehabilitation business to PE firm1
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1